FIGURE 5.
Olfactory mucosa mesenchymal stem cell (OM-MSC) injection reduced the cerebral infarction volume and alleviated neurologic deficits in ischemia/reperfusion (I/R) rats. (A,B) The infarct volume was determined by 2,3,5-triphenyltetrazolium chloride (TTC) staining (n = 3 animals per group). (C,D) The line charts show the results of the modified neurologic severity score (mNSS; n = 12 animals per group) and rotarod treadmill (n = 12 animals per group). Data are shown as the mean ± SEM. *p ≤ 0.05, ***p < 0.001, compared with the sham group and &p ≤ 0.05, &&p < 0.01, and &&&p < 0.001, compared with the I/R group.